Experienced in Infantile Pneumothorax

Dr. Philip J. Rosenthal

Pediatrics | Pediatric Gastroenterology | Gastroenterology
San Francisco, CA 
Clinical Trials:Currently Recruiting for 2 Trials
47 Years of Experience
Experienced in Infantile Pneumothorax
San Francisco, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Philip Rosenthal is a Pediatrics specialist and a Pediatric Gastroenterologist in San Francisco, California. Dr. Rosenthal has been practicing medicine for over 47 years and is rated as an Experienced provider by MediFind in the treatment of Infantile Pneumothorax. His top areas of expertise are Alagille Syndrome, Biliary Atresia, Cholestasis, Hepatitis, and Liver Transplant.

His clinical research consists of co-authoring 515 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Infantile Pneumothorax.

Specialties
Pediatrics
Pediatric Gastroenterology
Gastroenterology
Licenses
Pediatrics in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID

Locations

San Francisco, CA 94143

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 2b, Double-Blind, Three Arm, Randomized, Placebo Controlled Trial With Restricted Response Adaptive Randomization Testing the Efficacy and Safety of High Dose Methylprednisolone or Equine Anti-Thymocyte Globulin as Treatment for Acute Liver Failure in Pediatric Patients
A Phase 2b, Double-Blind, Three Arm, Randomized, Placebo Controlled Trial With Restricted Response Adaptive Randomization Testing the Efficacy and Safety of High Dose Methylprednisolone or Equine Anti-Thymocyte Globulin as Treatment for Acute Liver Failure in Pediatric Patients
Enrollment Status: Recruiting
Publish Date: November 04, 2025
Intervention Type: Drug
Study Drugs: Methylprednisolone, Equine anti-thymocyte globulin, Prednisolone, Diphenhydramine
Study Phase: Phase 2
Prospective Observational Study of Primary Sclerosing Cholangitis (PSC) in Children
Prospective Observational Study of Primary Sclerosing Cholangitis (PSC) in Children
Enrollment Status: Recruiting
Publish Date: September 08, 2025
A Placebo-Controlled, Multi-dose, Phase 2 Study to Determine the Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency (AATD) [SEQUOIA]
A Placebo-Controlled, Multi-dose, Phase 2 Study to Determine the Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency (AATD) [SEQUOIA]
Enrollment Status: Completed
Publish Date: November 04, 2025
Intervention Type: Other, Drug
Study Drug: ARO-AAT
Study Phase: Phase 2
Open-Label, Phase 2 Study to Evaluate the Safety and Tolerability of Maralixibat in the Treatment of Infants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis and Alagille Syndrome
Open-Label, Phase 2 Study to Evaluate the Safety and Tolerability of Maralixibat in the Treatment of Infants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis and Alagille Syndrome
Enrollment Status: Completed
Publish Date: February 06, 2025
Intervention Type: Drug
Study Drug: Maralixibat
Study Phase: Phase 2
A Phase 3 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT)
A Phase 3 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: Odevixibat
Study Phase: Phase 3
Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Database 2
Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Database 2
Enrollment Status: Completed
Publish Date: February 23, 2022
Losartan for the Treatment of Pediatric NAFLD (STOP-NAFLD): A Phase 2, Randomized, Placebo-Controlled Clinical Trial
Losartan for the Treatment of Pediatric NAFLD (STOP-NAFLD): A Phase 2, Randomized, Placebo-Controlled Clinical Trial
Enrollment Status: Terminated
Publish Date: October 21, 2021
Intervention Type: Drug
Study Phase: Phase 2
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Enrollment Status: Completed
Publish Date: October 26, 2017
Intervention Type: Drug
Study Phase: Phase 1
View 6 Less Clinical Trials

514 Total Publications

Recurrent Plasmodium falciparum parasitemia and drug resistance mutations during intermittent preventive treatment of malaria in pregnancy in Uganda.
Recurrent Plasmodium falciparum parasitemia and drug resistance mutations during intermittent preventive treatment of malaria in pregnancy in Uganda.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Similar Doctors
Jochen Profit
Distinguished in Infantile Pneumothorax
Dr. Jochen Profit
Neonatology | Pediatrics
Distinguished in Infantile Pneumothorax
Dr. Jochen Profit
Neonatology | Pediatrics
725 Welch Rd, 
Palo Alto, CA 
 (27.0 miles away)
650-497-8000
Languages Spoken:
English
See accepted insurances

Jochen Profit is a Neonatologist and a Pediatrics provider in Palo Alto, California. Dr. Profit is rated as an Advanced provider by MediFind in the treatment of Infantile Pneumothorax. His top areas of expertise are Infantile Pneumothorax, Premature Infant, Bronchopulmonary Dysplasia, and Intraventricular Hemorrhage of the Newborn.

Advanced in Infantile Pneumothorax
Dr. James Xie
Pediatrics
Advanced in Infantile Pneumothorax
Dr. James Xie
Pediatrics

Lucile Packard Children's Hospital Stanford

725 Welch Rd, 
Palo Alto, CA 
 (27.0 miles away)
650-497-8000
Languages Spoken:
English

James Xie is a Pediatrics provider in Palo Alto, California. Dr. Xie is rated as an Advanced provider by MediFind in the treatment of Infantile Pneumothorax. His top areas of expertise are Infantile Pneumothorax and Acute Pain.

Advanced in Infantile Pneumothorax
Dr. Daniel S. Tawfik
Intensive Care Medicine | Pediatrics
Advanced in Infantile Pneumothorax
Dr. Daniel S. Tawfik
Intensive Care Medicine | Pediatrics

Lpch Medical Group Div Of Lucile

725 Welch Rd, 
Palo Alto, CA 
 (27.0 miles away)
650-498-7200
Languages Spoken:
English
See accepted insurances

Daniel Tawfik is an Intensive Care Medicine specialist and a Pediatrics provider in Palo Alto, California. Dr. Tawfik is rated as an Experienced provider by MediFind in the treatment of Infantile Pneumothorax. His top areas of expertise are Infantile Pneumothorax, Rasmussen Encephalitis, Urea Cycle Disorders (UCD), and Newborn Jaundice.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rosenthal's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile